Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
Introduction: Calcimimetics improve parameters of secondary hyperparathyroidism (sHPT) but are mostly initiated when patients have severe disease, potentially limiting effectiveness. We evaluated the effects of etelcalcetide on lowering intact parathyroid hormone, calcium, and phosphate at different...
Main Authors: | John Cunningham, Geoffrey A. Block, Glenn M. Chertow, Kerry Cooper, Pieter Evenepoel, Jan Iles, Yan Sun, Pablo Ureña-Torres, David A. Bushinsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024919301573 |
Similar Items
-
An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.
by: Geoffrey A Block, et al.
Published: (2019-01-01) -
Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
by: Eidman KE, et al.
Published: (2018-02-01) -
Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
by: Cozzolino M, et al.
Published: (2017-06-01) -
Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
by: Domenico Russo, et al.
Published: (2019-07-01) -
Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
by: Yuka Kurokawa, et al.
Published: (2020-12-01)